|
|
|
|
European Pharmaceutical Contractor |
| |
|
European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.
Each quarterly edition examines areas of importance – both economic and technical – to contract research organisations, contract manufacturers, regulatory controllers, consultants and analysts. This enables regulatory bodies to link directly with policy-makers both in major contractor groups and pharmaceutical companies, and thereby convey regulatory information directly from the governing bodies, but also ensure debate between the policy-makers and consultancy groups.
Set up in December 2009, EPC’s board of Industry Advisers help develop the content of the magazine, using first-hand experience to keep the magazine focused on the latest developments in the industry.
Anne Maria Ylisaari
Senior Manager, Global Clinical Alliances & Sourcing
Orion Pharma Development
Beatrijs Van Liedekerke
Director, Advisory Services
PricewaterhouseCoopers
Henrietta Ukwu
Senior Vice President, Global Regulatory Affairs
PPD, Inc
Jane Clarke
Director, eTMF Document Solutions and System Development
Phlexglobal
|
|
|
|
|
|
 |
Industry Events |
 |
HPLC 2014 New Orleans
11-15 May 2014, New Orleans, LA, USA
Don't miss the Largest International Liquid-phase Separations Conference
and Exhibition of the Year, HPLC 2014 on May 11-15, 2014 in New Orleans, LA,
USA.
More info >> |
|
 |
News and Press Releases |
 |
INC Research Expands Clinical Pharmacology Team to Support Early Phase Business Unit
Raleigh, N.C., Feb. 6, 2014 – INC Research, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced the appointment of Beatrice Setnik, PhD, as Vice President, Clinical Pharmacology. Dr. Setnik will support INC Research’s world-class Early Phase Business Unit, providing scientific direction on matters related to abuse liability.
More info >> |
|
 |
White Papers |
 |
|
Choosing the Right CMO for HPAPI Manufacturing
AMRI
Over the past few years a steady stream of contract manufacturing organizations (CMO) have added high potency active pharmaceutical ingredient (HPAPI) production capacity. The expansions give biopharma executives charged with selecting HPAPI production partners an unprecedented number of options, but all this choice creates a problem — which CMO should you pick when each is touting similar technical capabilities?
More info >> |
|
|
